Skip to content
10-Q

Quarterly Report

Regenicin, Inc.

0001662252-23-000017

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Apr 4, 2023 153.48M sh
Shares Diluted Q1 2023 · Mar 31, 2023 153.48M sh
Shares Diluted Q1 2023 · Mar 31, 2023 153.48M sh
Shares Diluted Q1 2023 · Mar 31, 2022 153.48M sh
Shares Diluted Q1 2023 · Mar 31, 2022 153.48M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$690.07K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$17.15K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$6.21M
Stockholders Equity restated Q1 2023 · Dec 31, 2022 −$5.93M
Stockholders Equity Q1 2023 · Sep 30, 2022 −$5.6M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$5.28M
Current Liabilities Q1 2023 · Mar 31, 2023 $18.07M
Current Liabilities Q1 2023 · Sep 30, 2022 $5.61M
Total Assets Q1 2023 · Mar 31, 2023 $11.86M
Total Assets Q1 2023 · Sep 30, 2022 $15.49K
Eps Diluted Q1 2023 · Mar 31, 2023 $0.00
Eps Diluted Q1 2023 · Mar 31, 2023 $0.00
Eps Diluted Q1 2023 · Mar 31, 2022 $0.00
Eps Diluted Q1 2023 · Mar 31, 2022 $0.00
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2023 $233.09K
Sga Expense Q1 2023 · Mar 31, 2023 $163.2K
Sga Expense Q1 2023 · Mar 31, 2022 $155.51K
Sga Expense Q1 2023 · Mar 31, 2022 $302.05K
Rd Expense Q1 2023 · Mar 31, 2023 $94.74K
Rd Expense Q1 2023 · Mar 31, 2023 $432.26K
Net Income Q1 2023 · Mar 31, 2023 −$336.44K
Net Income Q1 2023 · Mar 31, 2023 −$613.95K
Net Income Q1 2023 · Dec 31, 2022 −$277.51K
Net Income Q1 2023 · Mar 31, 2022 −$166.65K
Net Income Q1 2023 · Mar 31, 2022 −$320.77K